- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05581602
Actimetry Monitoring of the Paretic Upper Limb in Chronic Post Stroke. (ParUse)
Actimeric Monitoring of the Use of the Paretic Upper Limb in the Activities of Daily Living of the Post-chronic Stroke Subject in a Home Environment
After a stroke, 80% of patients continue to have difficulty using their paretic upper limb in activities of daily living (ADL) despite post-stroke rehabilitation practices that aim to promote the use of the paretic upper limb. It is known that functional recovery depends on actual use (Use it or Loose it), but one-time measurements in the clinic do not allow quantification of the actual use of the paretic upper limb in daily life (in the person's living environment).
The investigators hypothesize the feasibility of quantifying functional use of the paretic upper limb by actimetry in clinical routine.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After a stroke, 80% of patients continue to have difficulty using their paretic upper limb in activities of daily living (ADL) despite post-stroke rehabilitation practices that aim to promote the use of the paretic upper limb. It is known that functional recovery depends on actual use (Use it or Loose it), but one-time measurements in the clinic do not allow quantification of the actual use of the paretic upper limb in daily life (in the person's living environment).
Project will monitor 30 chronic and 30 healthy subjects over one week period using two wrist worn sensors .
The main objective is to objectively quantify by actimetry, over 7 days, the real functional use of the paretic upper limb in the activities of daily living of post-stroke hemiparetic subjects in chronic phase, by the functional use ratio between the two arms (UseRatio).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karima BAKHTI, PhD
- Phone Number: +33 0467336111
- Email: k-bakhti@chu-montpellier.fr
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- University Hospital of Montpellier
-
Contact:
- Karima BAKHTI, PhD
- Phone Number: +33 0467336111
- Email: k-bakhti@chu-montpellier.fr
-
Nîmes, France, 30900
- Recruiting
- Jerome FROGER
-
Contact:
- Jerome FROGER
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Inclusion criteria common to all participants:
- Be between 18 and 90 years old
Post-stroke subjects should:
- Having a stroke with motor sequelae in the upper limb
- Be in the chronic phase (>3 months post-stroke) of a stroke whatever the aetiology
Exclusion Criteria:
Non inclusion criteria common to all participants:
- Absence of free, informed and express oral consent
- No affiliation to a French social security system or beneficiary of such a system
- Patient protected by law
- Pregnant or breastfeeding women
Not eligible for inclusion, post-stroke subjects:
- Not understanding the constraints of the study
- Have cognitive impairments that prevent them from understanding the study
- With a known hemigligence in the medical record (omission > 8 on bells test)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hemiparetic post-stroke subjects
Stroke patients with motor sequelae in the upper limb.
|
Participants will be required to wear wristbands containing an accelerometer on each wrist.
The bracelets will be kept on both wrists for 7 days with permission to remove them from time to time.
|
|
Other: Healthy subjects
Subjects without stroke.
|
Participants will be required to wear wristbands containing an accelerometer on each wrist.
The bracelets will be kept on both wrists for 7 days with permission to remove them from time to time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FuncUseRatio
Time Frame: 7 days
|
The paretic functional use score is a ratio of functional movements performed by the paretic upper limb to the sum of functional movements performed by the paretic and non-paretic upper limbs (in percentage %).
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use
Time Frame: 7 days
|
Measurement of the amount of functional movement of each upper limb, in an ecological situation during activities of daily living of post-stroke and healthy subjects.
|
7 days
|
|
Intensity
Time Frame: 7 days
|
Measurement of the intensity of movements (functional and non-functional) of each upper limb, in an ecological situation during activities of daily living of post-stroke and healthy subjects.
|
7 days
|
|
Profil
Time Frame: During intervention
|
The activity log is presented in the form of a table.
The columns represent the days of recording (Day 1 => Day 7), the rows represent the time slots hour by hour
|
During intervention
|
|
Motor deficit
Time Frame: During the inclusion visit or information taken in the medical file
|
Motor deficit will be measured by the Fugl-Meyer Upper Extremity (FM-UE)
|
During the inclusion visit or information taken in the medical file
|
|
Dispersion of UseRatio
Time Frame: 6 months
|
The dispersion of UseRatio (UseRatioDisp) over the 6 repeated measurements will be measured by the intra-patient interquartile range
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL21_0512
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Stroke
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Karabuk UniversityRecruitingChronic StrokeTurkey (Türkiye)
-
Marina Castel SánchezNot yet recruiting
-
Karabuk UniversityRecruiting
-
Zikra AzharRecruitingChronic StrokePakistan
-
Sierra Varona SLNot yet recruiting
-
Montiha AzeemRecruitingChronic Ischemic StrokePakistan
-
Riphah International UniversityNot yet recruitingChronic Stroke PatientsPakistan
-
HealthPartners InstituteRecruitingChronic Stroke PatientsUnited States
-
Nisha FazalRecruiting
Clinical Trials on Wearing bracelets (3-Axis Logging Accelerometer)
-
Tel-Aviv Sourasky Medical CenterNot yet recruitingParkinson Disease | Freezing of GaitIsrael
-
Imperial College LondonCompletedSurgery | Technology | Enhanced RecoveryUnited Kingdom